|
|
Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance
B. Le Daré
,
L. Triquet
,
A. Degremont
,
H. Charbonnel
,
A. Default
et al.
Journal articles
hal-02865292v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pregnancy outcomes in a French cohort of patients with Multiple Sclerosis: the MUSTANG project
Hélène Tillaut
,
A.S. Kerbrat
,
A. Degremont
,
Elisabeth Polard
,
Emmanuelle Leray
et al.
European Journal of Neurology, 2020, 27, pp.476-476
Journal articles
hal-02887183v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age
A. Degremont
,
B. Le Nautout
,
C. Rault
,
E. Oger
,
A. Biraben
et al.
Fundamental & Clinical Pharmacology, 2018, 32, pp.6-6
Journal articles
hal-01833091v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Medical care of pregnant women treated by sodium valproate observational study from the French medico-administrative database from 2011 to 2016
A. Degremont
,
E. Polard
,
S. Kerbrat
,
E. Oger
,
C. Rault
et al.
Fundamental & Clinical Pharmacology, 2018, 32, pp.46-46
Journal articles
hal-01833099v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety Profile of Cabazitaxel: A French Pharmacovigilance Database Analysis
C. Chinchilla
,
M. N. Osmont
,
A. Degremont
,
E. Oger
,
E. Polard
et al.
Drug Safety, 2021, 44 (12), pp.1425-1426
Journal articles
hal-03512914v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Trends of sodium valproate prescriptions in children 0-14 years of age between 2010 and 2016 study from the French National Health Insurance Databases
E. Polard
,
A. Degremont
,
C. Rault
,
B. Le Nautout
,
E. Oger
et al.
Fundamental & Clinical Pharmacology, 2018, 32, pp.27-27
Journal articles
hal-01833098v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|